269 related articles for article (PubMed ID: 26104346)
1. New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli.
Melton-Celsa AR; O'Brien AD
Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104346
[TBL] [Abstract][Full Text] [Related]
2. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.
Ardissino G; Vignati C; Masia C; Capone V; Colombo R; Tel F; Daprai L; Testa S; Dodaro A; Paglialonga F; Luini M; Brigotti M; Picicco D; Baldioli C; Pagani F; Ceruti R; Tommasi P; Possenti I; Cresseri D; Consonni D; Montini G; Arghittu M;
J Pediatr; 2021 Oct; 237():34-40.e1. PubMed ID: 34197890
[TBL] [Abstract][Full Text] [Related]
3. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
[TBL] [Abstract][Full Text] [Related]
4. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.
Ardissino G; Possenti I; Vignati C; Daprai L; Capone V; Brigotti M; Luini MV; Consonni D; Montini G
Pediatr Nephrol; 2020 Oct; 35(10):1997-2001. PubMed ID: 32734345
[TBL] [Abstract][Full Text] [Related]
5. Relationship between pathogenicity for humans and stx genotype in Shiga toxin-producing Escherichia coli serotype O157.
Kawano K; Okada M; Haga T; Maeda K; Goto Y
Eur J Clin Microbiol Infect Dis; 2008 Mar; 27(3):227-32. PubMed ID: 18071766
[TBL] [Abstract][Full Text] [Related]
6. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
[TBL] [Abstract][Full Text] [Related]
7. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.
Ritchie JM; Wagner PL; Acheson DW; Waldor MK
Appl Environ Microbiol; 2003 Feb; 69(2):1059-66. PubMed ID: 12571029
[TBL] [Abstract][Full Text] [Related]
9. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina.
Rivas M; Miliwebsky E; Chinen I; Roldán CD; Balbi L; García B; Fiorilli G; Sosa-Estani S; Kincaid J; Rangel J; Griffin PM;
Foodborne Pathog Dis; 2006; 3(1):88-96. PubMed ID: 16602984
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Shiga-toxigenic Escherichia coli isolated from cases of diarrhoea & haemolytic uremic syndrome in north India.
Kumar A; Taneja N; Bharti B; Sharma M
Indian J Med Res; 2014 Dec; 140(6):778-84. PubMed ID: 25758577
[TBL] [Abstract][Full Text] [Related]
11. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
Mody RK; Luna-Gierke RE; Jones TF; Comstock N; Hurd S; Scheftel J; Lathrop S; Smith G; Palmer A; Strockbine N; Talkington D; Mahon BE; Hoekstra RM; Griffin PM
Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280
[TBL] [Abstract][Full Text] [Related]
12. [Role of the Shiga toxin in the hemolytic uremic syndrome].
Creydt VP; Nuñez P; Boccoli J; Silberstein C; Zotta E; Goldstein J; Ibarra C
Medicina (B Aires); 2006; 66 Suppl 3():11-5. PubMed ID: 17354471
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006.
Hedican EB; Medus C; Besser JM; Juni BA; Koziol B; Taylor C; Smith KE
Clin Infect Dis; 2009 Aug; 49(3):358-64. PubMed ID: 19548834
[TBL] [Abstract][Full Text] [Related]
14. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
Müthing J; Schweppe CH; Karch H; Friedrich AW
Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
[TBL] [Abstract][Full Text] [Related]
15. Rapid and sensitive detection of Shiga toxin-producing Escherichia coli directly from stool samples by real-time PCR in comparison to culture, enzyme immunoassay and Vero cell cytotoxicity assay.
Gerritzen A; Wittke JW; Wolff D
Clin Lab; 2011; 57(11-12):993-8. PubMed ID: 22239032
[TBL] [Abstract][Full Text] [Related]
16. [The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission].
Rivas M; Miliwebsky E; Chinen I; Deza N; Leotta GA
Medicina (B Aires); 2006; 66 Suppl 3():27-32. PubMed ID: 17354474
[TBL] [Abstract][Full Text] [Related]
17. Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011.
Werber D; King LA; Müller L; Follin P; Buchholz U; Bernard H; Rosner B; Ethelberg S; de Valk H; Höhle M
Am J Epidemiol; 2013 Sep; 178(6):984-92. PubMed ID: 23935124
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of Shiga-toxin producing escherichia coli.
Melton-Celsa A; Mohawk K; Teel L; O'Brien A
Curr Top Microbiol Immunol; 2012; 357():67-103. PubMed ID: 21915773
[TBL] [Abstract][Full Text] [Related]
19. Recent Updates on Outbreaks of Shiga Toxin-Producing
Kim JS; Lee MS; Kim JH
Front Cell Infect Microbiol; 2020; 10():273. PubMed ID: 32582571
[TBL] [Abstract][Full Text] [Related]
20. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.
Friedrich AW; Bielaszewska M; Zhang WL; Pulz M; Kuczius T; Ammon A; Karch H
J Infect Dis; 2002 Jan; 185(1):74-84. PubMed ID: 11756984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
